The Pancreatitis drugs in development market research report provides comprehensive information on the therapeutics under development for Pancreatitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Pancreatitis. Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Pancreatitis and features dormant and discontinued products.
GlobalData tracks 38 drugs in development for Pancreatitis by 32 companies/universities/institutes. The top development phase for Pancreatitis is preclinical with 20 drugs in that stage. The Pancreatitis pipeline has 32 drugs in development by companies and six by universities/ institutes. Some of the companies in the Pancreatitis pipeline products market are: CalciMedica, Daewoong Pharmaceutical and Cypralis.
The key targets in the Pancreatitis pipeline products market include Cholecystokinin Receptor, Calcium Release Activated Calcium Channel Protein 1, and ORAI Calcium Release Activated Calcium Modulator.
The key mechanisms of action in the Pancreatitis pipeline product include Cholecystokinin Receptor Antagonist with two drugs in Preclinical. The Pancreatitis pipeline products include five routes of administration with the top ROA being Intravenous and seven key molecule types in the Pancreatitis pipeline products market including Small Molecule, and Cell Therapy.
Pancreatitis overview
Pancreatitis is an inflammation of the pancreas. Symptoms include nausea, vomiting, tenderness when touching the abdomen, weight loss, and upper abdominal pain. Predisposing factors include alcoholism, smoking, family history of pancreatitis, infection, injury to the abdomen, and pancreatic cancer. Treatment includes antibiotics and medication to relieve pain.
For a complete picture of Pancreatitis’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
